GLI2 (hub1), SMO (hub2), and CSF1 (hub3) were the top three, suggesting their expression patterns play key regulatory roles in promoting AD or CAA pathology (Fig. 3F and G). The gene discussed is CSF1; the disease is Alzheimer disease.